Santa Clara, CA – According to filings with the U.S. Securities and Exchange Commission, Invicta Medical is raising $5,705,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Rick Oconnor played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Invicta Medical
Invicta Medical is a medical technology company that specializes in innovative therapies for sleep apnea. Invicta Medical is a clinical-stage medical technology company developing a first-of-its-kind treatment for sleep apnea. Invictas intelligent neurostimulation wearable is designed to address the shortcomings of existing therapies, which are expensive, intrusive and yield low patient compliance rates. Invicta has raised $28.6 million in funding since 2013 and is backed by international investors and Tier 1 investment firms. Invictas Board of Directors have extensive operational and financial experience in industries ranging from medical technologies and life sciences to semiconductors to robotics, while its Scientific Advisors hail from top universities and medical institutions, including Stanford University, John Hopkins University, Karolinska Institute and the University of Pittsburgh Medical Center.

To learn more about Invicta Medical, visit http://www.invictamedical.com/

Contact:
Rick Oconnor, President and Chief Executive Officer
650-868-7049
https://www.linkedin.com/in/rickoconnor1/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved